Analysis of F8 inversions as risk factors for FVIII inhibitor development in Indian severe haemophilia A patients

被引:4
|
作者
Pinto, Patricia [1 ]
Ghosh, Kanjaksha [1 ]
Shetty, Shrimati [1 ]
机构
[1] ICMR, Natl Inst Immunohaematol, Mumbai 400012, Maharashtra, India
关键词
FVIII inhibitors; F8; inversions; Haemophilia A; India; FACTOR-VIII INHIBITORS; GENE;
D O I
10.1016/j.bcmd.2014.04.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
FVIII inhibitor development in haemophilia A (HA) patients, especially those with severe manifestations is a serious adverse effect in patients with haemophilia A, and the clinical management of these patients is very difficult as most don't respond to conventional treatment. Many genetic and non-genetic risk factors have been proposed however, these are diverse in different population groups, highlighting the importance of determining specific risk factors for each population. F8 mutations and especially inversions, which are the most common causative mutation in severe HA, have been significantly associated with inhibitor development earlier, however there is no conclusive data so far with regard to Indian haemophiliacs. This study provides novel evidence that intron 22 inversions in the F8 gene are indeed significantly associated with FVIII inhibitor development in Indian haemophiliacs. Further studies with other risk factors would enable better insights into the immune response towards FVIII in these patients, and possibly help to characterize patients at a higher risk for inhibitor development. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:161 / 163
页数:3
相关论文
共 50 条
  • [1] A study of risk factors for the development of FVIII inhibitors in Indian severe haemophilia A patients
    Pinto, P.
    Ghosh, K.
    Shetty, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1080 - 1080
  • [2] FVIII inhibitor risk correlated with F8 gene variants in 296 unrelated male Chinese patients with haemophilia A
    Kang, Hongfei
    Li, Jingjing
    Chen, Shengmei
    Li, Bai
    Feng, Yin
    Kong, Xiangdong
    HAEMOPHILIA, 2021, 27 (02) : E274 - E277
  • [3] Influence of the type of F8 gene mutation on inhibitor development in a single centre cohort of severe haemophilia A patients
    Gouw, S. C.
    Van der Bom, J. G.
    Van den Berg, H. M.
    Zewald, R. A.
    Van Amstel, J. K. Ploos
    Mauser-Bunschoten, E. P.
    HAEMOPHILIA, 2011, 17 (02) : 275 - 281
  • [4] F8 gene dosage defects in atypical patients with severe haemophilia A
    Vencesla, A.
    Baena, M.
    Garrido, R. P.
    Nunez, R.
    Velasco, F.
    Rosell, J.
    Villar, A.
    Jimenez-Yuste, V.
    Baiget, M.
    Tizzano, E. F.
    HAEMOPHILIA, 2012, 18 (05) : 708 - 713
  • [5] Quantitative expression analysis of the F8 mRNA in haemophilia A patients with no detectable mutation in the F8 gene
    El-Maarri, O.
    Nuesgen, N.
    Mueller, J.
    Oldenburg, J.
    HAMOSTASEOLOGIE, 2009, 29 : S113 - S115
  • [6] Distribution of F8 Gene Mutations in 81 Inhibitor-Free, Severe Hemophilia a Patients with Full Exposure to FVIII
    Pavlova, Anna
    Matytsina, Irina
    Arai, Morio
    Oldenburg, Johannes
    BLOOD, 2014, 124 (21)
  • [7] Inhibitor development after switching of FVIII concentrate in multitransfused patients with severe haemophilia A
    Aznar, J. A.
    Moret, A.
    Ibanez, F.
    Vila, C.
    Cabrera, N.
    Mesa, E.
    Bonanad, S.
    HAEMOPHILIA, 2014, 20 (05) : 624 - 629
  • [8] A single causative mutation in the promoter region of F8 gene associated with FVIII inhibitor development
    Costa, C.
    Repesse, Y.
    Gautier, P.
    Goossens, M.
    Borel-Derlon, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 830 - 830
  • [9] In silico calculated affinity of FVIII-derived peptides for HLA class II alleles predicts inhibitor development in haemophilia A patients with missense mutations in the F8 gene
    Pashov, A. D.
    Calvez, T.
    Gilardin, L.
    Maillere, B.
    Repesse, Y.
    Oldenburg, J.
    Pavlova, A.
    Kaveri, S. V.
    Lacroix-Desmazes, S.
    HAEMOPHILIA, 2014, 20 (02) : 176 - 184
  • [10] F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis
    Gouw, Samantha C.
    van den Berg, H. Marijke
    Oldenburg, Johannes
    Astermark, Jan
    de Groot, Philip G.
    Margaglione, Maurizio
    Thompson, Arthur R.
    van Heerde, Waander
    Boekhorst, Jorien
    Miller, Connie H.
    le Cessie, Saskia
    van der Bom, Johanna G.
    BLOOD, 2012, 119 (12) : 2922 - 2934